A single-nuclei paired multiomic analysis of the human midbrain reveals age- and Parkinson's disease-associated glial changes.
Levi AdamsMin Kyung SongSamantha YuenYoshiaki TanakaYoon-Seong KimPublished in: Nature aging (2024)
Age is the primary risk factor for Parkinson's disease (PD), but how aging changes the expression and regulatory landscape of the brain remains unclear. Here we present a single-nuclei multiomic study profiling shared gene expression and chromatin accessibility of young, aged and PD postmortem midbrain samples. Combined multiomic analysis along a pseudopathogenesis trajectory reveals that all glial cell types are affected by age, but microglia and oligodendrocytes are further altered in PD. We present evidence for a disease-associated oligodendrocyte subtype and identify genes lost over the aging and disease process, including CARNS1, that may predispose healthy cells to develop a disease-associated phenotype. Surprisingly, we found that chromatin accessibility changed little over aging or PD within the same cell types. Peak-gene association patterns, however, are substantially altered during aging and PD, identifying cell-type-specific chromosomal loci that contain PD-associated single-nucleotide polymorphisms. Our study suggests a previously undescribed role for oligodendrocytes in aging and PD.
Keyphrases
- gene expression
- genome wide
- single cell
- transcription factor
- dna methylation
- dna damage
- endothelial cells
- poor prognosis
- neuropathic pain
- oxidative stress
- cell therapy
- induced apoptosis
- stem cells
- copy number
- long non coding rna
- cell proliferation
- signaling pathway
- spinal cord
- white matter
- mesenchymal stem cells
- binding protein
- blood brain barrier